Methyllycaconitine (MLA) citrate is a potent, selective, CNS-penetrant, competitive alpha7nAChR antagonist. Methyllycaconitine citrate alleviates amyloid-beta peptides-induced cytotoxicity in SH-SY5Y cells. Methyllycaconitine citrate prevents methamphetamine-induced effects in mouse striatum. Methyllycaconitine citrate can be used for neurological disease research, such as Alzheimers disease [1][2][3].
Molekulargewicht:
874.92
Reinheit:
99.58
CAS Nummer:
[351344-10-0]
Formel:
C43H58N2O17
Target-Kategorie:
nAChR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten